{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T07:58:54Z","timestamp":1790236734392,"version":"4.1.0"},"reference-count":33,"publisher":"Ovid Technologies (Wolters Kluwer Health)","funder":[{"name":"Noncommunicable Chronic Diseases-National Science and Technology Major Project","award":["2025ZD0548200"],"award-info":[{"award-number":["2025ZD0548200"]}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The high-sensitivity C-reactive protein triglyceride glucose index (CTI) integrates metabolic dysregulation and systemic inflammation, whereas moderate-to-severe coronary artery calcification (MSCAC) reflects anatomic atherosclerotic burden. Whether CTI prognostic value varies by MSCAC status and whether these measures interact clinically remains unclear.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This prospective cohort study included 22 218 patients with angiography\u2011confirmed coronary artery disease (CAD) enrolled from January 2017 to December 2018, categorized by CTI median (\u22649.08 vs. &gt;9.08) and MSCAC presence. CTI was calculated as Ln(fasting glucose [mg\/dl] \u00d7 triglycerides [mg\/dl])\/2 + Ln(hs\u2011CRP [mg\/L])\u2005\u00d7\u20050.412. The primary endpoint was cardiovascular events; the secondary endpoint was major adverse cardiovascular and cerebrovascular events (MACCE). Restricted cubic spline, Kaplan\u2013Meier, and Cox regression analyses were applied.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Each 1-unit CTI increase was associated with 15% higher cardiovascular event risk [hazard ratio: 1.15, 95% confidence interval (CI): 1.02\u20131.29] and 9% higher MACCE risk (hazard ratio: 1.09, 95% CI: 1.03\u20131.15). MSCAC independently conferred a 32% higher risk of cardiovascular events (hazard ratio: 1.32, 95% CI: 1.05\u20131.67) and 23% higher MACCE risk (hazard ratio: 1.23, 95% CI: 1.10\u20131.38). Patients with both elevated CTI and MSCAC had 66% increased cardiovascular event risk (hazard ratio: 1.66, 95% CI: 1.20\u20132.30) and 38% increased MACCE risk (hazard ratio: 1.38, 95% CI: 1.18\u20131.62) versus neither. No statistically significant additive or multiplicative interaction was detected.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>In patients with CAD, elevated CTI and MSCAC independently portend adverse outcomes, and their coexistence identifies a particularly high\u2011risk phenotype. These findings support the complementary value of metabolic\u2011inflammatory and anatomic measures in risk stratification.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/mca.0000000000001681","type":"journal-article","created":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T07:00:09Z","timestamp":1790233209000},"update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Joint association of high-sensitivity C-reactive protein\u2013triglyceride glucose index and coronary artery calcification with adverse outcomes in patients with coronary artery disease: a large-scale cohort study"],"prefix":"10.1097","author":[{"given":"Song","family":"Wen","sequence":"first","affiliation":[{"name":"Cardiometabolic Medicine Center"},{"name":"Department of Cardiology, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College"},{"name":"State Key Laboratory of Cardiovascular Disease, Beijing, China"},{"name":"Song Wen, Zhanyuan Chen, and Rui Fu contributed equally to the writing of this article."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhanyuan","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College"},{"name":"Song Wen, Zhanyuan Chen, and Rui Fu contributed equally to the writing of this article."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Fu","sequence":"additional","affiliation":[{"name":"Cardiometabolic Medicine Center"},{"name":"Department of Cardiology, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College"},{"name":"State Key Laboratory of Cardiovascular Disease, Beijing, China"},{"name":"Song Wen, Zhanyuan Chen, and Rui Fu contributed equally to the writing of this article."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingbing","family":"Meng","sequence":"additional","affiliation":[{"name":"Cardiometabolic Medicine Center"},{"name":"Department of Cardiology, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College"},{"name":"State Key Laboratory of Cardiovascular Disease, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bowen","family":"Li","sequence":"additional","affiliation":[{"name":"Cardiometabolic Medicine Center"},{"name":"Department of Cardiology, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College"},{"name":"State Key Laboratory of Cardiovascular Disease, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kefei","family":"Dou","sequence":"additional","affiliation":[{"name":"Cardiometabolic Medicine Center"},{"name":"Department of Cardiology, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College"},{"name":"State Key Laboratory of Cardiovascular Disease, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,9,24]]},"reference":[{"key":"R1-20260924","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1016\/j.jacc.2025.08.015","article-title":"Global, regional, and national burden of cardiovascular diseases and risk factors in 204 countries and territories, 1990-2023.","volume":"86","year":"2025","journal-title":"J Am Coll Cardiol"},{"key":"R2-20260924","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1093\/eurjpc\/zwae281","article-title":"Global burden of cardiovascular diseases: projections from 2025 to 2050.","volume":"32","author":"Chong","year":"2025","journal-title":"Eur J Prev Cardiol"},{"key":"R3-20260924","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1016\/j.jacc.2025.08.047","article-title":"Inflammation and cardiovascular disease: 2025 ACC Scientific Statement: a report of the American College of Cardiology.","volume":"87","author":"Mensah","year":"2026","journal-title":"J Am Coll Cardiol"},{"key":"R4-20260924","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.atherosclerosis.2021.07.005","article-title":"Metabolic profiling links cardiovascular risk and vascular end organ damage.","volume":"331","author":"Streese","year":"2021","journal-title":"Atherosclerosis"},{"key":"R5-20260924","doi-asserted-by":"crossref","first-page":"3827","DOI":"10.1093\/eurheartj\/ehad484","article-title":"Perivascular adipose tissue as a source of therapeutic targets and clinical biomarkers.","volume":"44","author":"Antoniades","year":"2023","journal-title":"Eur Heart J"},{"key":"R6-20260924","doi-asserted-by":"crossref","first-page":"4737","DOI":"10.1093\/eurheartj\/ehaf606","article-title":"The evolving landscape of targets for lipid lowering: from molecular mechanisms to translational implications.","volume":"46","author":"Ballantyne","year":"2025","journal-title":"Eur Heart J"},{"key":"R7-20260924","doi-asserted-by":"crossref","first-page":"e23","DOI":"10.1016\/S2666-7568(22)00247-1","article-title":"Association of the triglyceride glucose index as a measure of insulin resistance with mortality and cardiovascular disease in populations from five continents (PURE study): a prospective cohort study.","volume":"4","author":"Lopez-Jaramillo","year":"2023","journal-title":"Lancet Healthy Longev"},{"key":"R8-20260924","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1186\/s12933-024-02230-1","article-title":"Triglyceride-glucose index is associated with myocardial ischemia and poor prognosis in patients with ischemia and no obstructive coronary artery disease.","volume":"23","author":"Zhang","year":"2024","journal-title":"Cardiovasc Diabetol"},{"key":"R9-20260924","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1186\/s12933-025-02937-9","article-title":"Triglyceride glucose index in patients with acute coronary syndrome undergoing percutaneous coronary intervention predicts cardiovascular events: a cohort study.","volume":"24","author":"Hu","year":"2025","journal-title":"Cardiovasc Diabetol"},{"key":"R10-20260924","doi-asserted-by":"crossref","first-page":"3863","DOI":"10.1093\/eurheartj\/ehaf281","article-title":"Low-density lipoprotein cholesterol, lipoprotein(a) and high-sensitivity C-reactive protein are independent predictors of cardiovascular events.","volume":"46","author":"Markus","year":"2025","journal-title":"Eur Heart J"},{"key":"R11-20260924","doi-asserted-by":"crossref","first-page":"105786","DOI":"10.1016\/j.ebiom.2025.105786","article-title":"The relationship of baseline high-sensitivity C-reactive protein with incident cardiovascular events and all-cause mortality over 20 years.","volume":"117","author":"Hartley","year":"2025","journal-title":"EBioMedicine"},{"key":"R12-20260924","doi-asserted-by":"crossref","DOI":"10.1093\/eurjpc\/zwaf740","article-title":"High-sensitivity C-reactive protein and cardiovascular events in a multi-ethnic cohort: the HELIUS study.","author":"Beverloo","year":"2025","journal-title":"Eur J Prev Cardiol"},{"key":"R13-20260924","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1186\/s12933-025-02876-5","article-title":"Association between the C-reactive protein-triglyceride glucose index and new-onset coronary heart disease among metabolically heterogeneous individuals.","volume":"24","author":"Chen","year":"2025","journal-title":"Cardiovasc Diabetol"},{"key":"R14-20260924","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1186\/s12933-025-02869-4","article-title":"Associations of cumulative exposure and dynamic trajectories of the C-reactive protein-triglyceride-glucose index with incident cardiovascular disease in middle-aged and older Chinese adults: a nationwide cohort study.","volume":"24","author":"Ma","year":"2025","journal-title":"Cardiovasc Diabetol"},{"key":"R15-20260924","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1186\/s12933-025-02848-9","article-title":"C-reactive protein-triglyceride glucose index in evaluating cardiovascular disease and all-cause mortality incidence among individuals across stages 0-3 of cardiovascular-kidney-metabolic syndrome: a nationwide prospective cohort study.","volume":"24","author":"Ou","year":"2025","journal-title":"Cardiovasc Diabetol"},{"key":"R16-20260924","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1016\/j.jacc.2014.01.017","article-title":"Coronary artery calcification: pathogenesis and prognostic implications.","volume":"63","author":"Madhavan","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"R17-20260924","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1016\/j.jcin.2020.03.053","article-title":"Coronary calcification and long-term outcomes according to drug-eluting stent generation.","volume":"13","author":"Guedeney","year":"2020","journal-title":"JACC Cardiovasc Interv"},{"key":"R18-20260924","doi-asserted-by":"crossref","first-page":"1406216","DOI":"10.3389\/fcvm.2024.1406216","article-title":"Ten-year trajectory of coronary artery calcification and risk of cardiovascular outcomes: the multi-ethnic study of atherosclerosis.","volume":"11","author":"Xie","year":"2024","journal-title":"Front Cardiovasc Med"},{"key":"R19-20260924","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1056\/NEJMoa072100","article-title":"Coronary calcium as a predictor of coronary events in four racial or ethnic groups.","volume":"358","author":"Detrano","year":"2008","journal-title":"N Engl J Med"},{"key":"R20-20260924","doi-asserted-by":"crossref","first-page":"S8","DOI":"10.2337\/dc15-S005","article-title":"(2) Classification and diagnosis of diabetes.","volume":"38","year":"2015","journal-title":"Diabetes Care"},{"key":"R21-20260924","doi-asserted-by":"crossref","first-page":"3021","DOI":"10.1093\/eurheartj\/ehy339","article-title":"2018 ESC\/ESH Guidelines for the management of arterial hypertension.","volume":"39","author":"Williams","year":"2018","journal-title":"Eur Heart J"},{"key":"R22-20260924","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1161\/01.CIR.91.7.1959","article-title":"Patterns of calcification in coronary artery disease. A statistical analysis of intravascular ultrasound and coronary angiography in 1155 lesions.","volume":"91","author":"Mintz","year":"1995","journal-title":"Circulation"},{"key":"R23-20260924","doi-asserted-by":"crossref","first-page":"e030625","DOI":"10.1161\/JAHA.123.030625","article-title":"Uric acid levels, number of standard modifiable cardiovascular risk factors, and prognosis in patients with coronary artery disease: a large cohort study in Asia.","volume":"12","author":"Cui","year":"2023","journal-title":"J Am Heart Assoc"},{"key":"R24-20260924","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1093\/eurheartj\/ehad304","article-title":"Novel mechanisms and therapeutic targets in atherosclerosis: inflammation and beyond.","volume":"44","author":"Weber","year":"2023","journal-title":"Eur Heart J"},{"key":"R25-20260924","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S0140-6736(17)32814-3","article-title":"Relationship of C-reactive protein reduction to cardiovascular event reduction following treatment with canakinumab: a secondary analysis from the CANTOS randomised controlled trial.","volume":"391","author":"Ridker","year":"2018","journal-title":"Lancet"},{"key":"R26-20260924","doi-asserted-by":"crossref","first-page":"4092","DOI":"10.1093\/eurheartj\/ehaa659","article-title":"Time-to-treatment initiation of colchicine and cardiovascular outcomes after myocardial infarction in the Colchicine Cardiovascular Outcomes Trial (COLCOT).","volume":"41","author":"Bouabdallaoui","year":"2020","journal-title":"Eur Heart J"},{"key":"R27-20260924","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1161\/CIRCULATIONAHA.124.069808","article-title":"Effect of colchicine on coronary plaque stability in acute coronary syndrome as assessed by optical coherence tomography: the COLOCT randomized clinical trial.","volume":"150","author":"Yu","year":"2024","journal-title":"Circulation"},{"key":"R28-20260924","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1056\/NEJMoa1912388","article-title":"Efficacy and safety of low-dose colchicine after myocardial infarction.","volume":"381","author":"Tardif","year":"2019","journal-title":"N Engl J Med"},{"key":"R29-20260924","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1001\/archinte.168.12.1333","article-title":"Coronary artery calcification compared with carotid intima-media thickness in the prediction of cardiovascular disease incidence: the multi-ethnic study of atherosclerosis (MESA).","volume":"168","author":"Folsom","year":"2008","journal-title":"Arch Intern Med"},{"key":"R30-20260924","first-page":"519","article-title":"Glycolipid metabolic disorders, metainflammation, oxidative stress, and cardiovascular diseases: unraveling pathways.","volume":"13","author":"de Lima","year":"2024","journal-title":"Biology (Basel)"},{"key":"R31-20260924","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/s41573-021-00198-1","article-title":"Targeting inflammation in atherosclerosis - from experimental insights to the clinic.","volume":"20","author":"Soehnlein","year":"2021","journal-title":"Nat Rev Drug Discov"},{"key":"R32-20260924","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1093\/eurheartj\/ehw024","article-title":"Residual inflammatory risk: addressing the obverse side of the atherosclerosis prevention coin.","volume":"37","author":"Ridker","year":"2016","journal-title":"Eur Heart J"},{"key":"R33-20260924","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1016\/j.jacc.2021.01.035","article-title":"Tracking residual risk: time for a change?","volume":"77","author":"Stone","year":"2021","journal-title":"J Am Coll Cardiol"}],"container-title":["Coronary Artery Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MCA.0000000000001681","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T07:00:13Z","timestamp":1790233213000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MCA.0000000000001681"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,24]]},"references-count":33,"URL":"https:\/\/doi.org\/10.1097\/mca.0000000000001681","relation":{},"ISSN":["0954-6928","1473-5830"],"issn-type":[{"value":"0954-6928","type":"print"},{"value":"1473-5830","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,24]]},"assertion":[{"value":"2026-08-05","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-09-13","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}